Rogers, James R.
Sarpatwari, Ameet
Desai, Rishi J.
Bohn, Justin M.
Khan, Nazleen F.
Kesselheim, Aaron S.
Fischer, Michael A.
Gagne, Joshua J.
Connolly, John G.
Article History
First Online: 1 August 2018
Compliance with Ethical Standards
:
: James R. Rogers previously served as a paid consultant to Aetion, Inc., a software company, for unrelated work; he is currently a student at the Department of Biomedical Informatics, Columbia University, New York, New York, USA. Ameet Sarpatwari previously served as a paid consultant to Aetion, Inc., for unrelated work. Rishi J. Desai was the principal investigator of a research grant from Merck to Brigham & Women’s Hospital for unrelated work. Aaron S. Kesselheim has received prior research grants from the FDA Office of Generic Drugs and Division of Health Communication, for unrelated work. Joshua J. Gagne has received salary support from grants from Novartis Pharmaceutical Corporation and Eli Lilly and Company to Brigham and Women’s Hospital and is a consultant to Aetion, Inc. and to Optum, Inc., all for unrelated work. Justin M. Bohn, Nazleen F. Khan, Michael A. Fischer, and John G. Connolly have no conflicts of interest.
: Drs. Sarpatwari and Kesselheim's work was funded by the Laura and John Arnold Foundation, as well as the Harvard Program in Therapeutic Science and Engelberg Foundation.